3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Myelodysplastic Syndromes
12
Hematologic Neoplasms
7
Lymphoma
6
Myeloproliferative Disorders
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Leukemia
5
Graft vs Host Disease
5
Primary Myelofibrosis
4
Lymphoma, Non-Hodgkin
4
Leukemia, Biphenotypic, Acute
4
Hodgkin Disease
4
Burkitt Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
3
Anemia, Refractory, with Excess of Blasts
3
Waldenstrom Macroglobulinemia
2
Thrombocythemia, Essential
2
Sezary Syndrome
2
Recurrence
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Polycythemia Vera
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Interventions
belantamab mafodotin
2
Dexamethasone
1
Cyclophosphamide
1
Bortezomib
1
Antineoplastic Protocols
1
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Amyloidosis
×
Tacrolimus
×
90 days
×
Clear all
No trials found.